Teva Pharmaceutical Industries Ltd (TEVJF) SEC Filings — 2025
13 SEC filings for Teva Pharmaceutical Industries Ltd (TEVJF) in 2025.
Filings
- Teva Pharmaceutical Industries Ltd 8-K Filing — 8-K · Dec 11, 2025
- Teva Swings to Profit on Revenue Growth, Reduced Impairments — 10-Q · Nov 5, 2025
- Teva Pharmaceutical Industries Ltd 8-K Filing — 8-K · Nov 5, 2025
- Teva's Q2 Revenue Hit by $32M Derivative Loss; Issues $1.8B in New Debt — 10-Q · Jul 30, 2025
- Teva Pharma Files 8-K on Operations & Financials — 8-K · Jul 30, 2025
- Teva Pharmaceuticals Files 8-K on Security Holder Vote Matters — 8-K · Jun 5, 2025
- Teva Pharmaceuticals Files 8-K on Material Agreement — 8-K · May 28, 2025
- Teva Pharma Files 8-K — 8-K · May 22, 2025
- Teva Pharma Repays Debt, Goodwill Impairment Nears $30B — 10-Q · May 7, 2025
- Teva Pharma Files 8-K on Operations and Financials — 8-K · May 7, 2025
- Teva Pharma Files DEF 14A on Executive Compensation — DEF 14A · Apr 9, 2025
- Teva's Goodwill Hits $29.55B, $500M Anti-TL1A Deal — 10-K · Feb 5, 2025
- Teva Pharmaceuticals Files 8-K on Financials — 8-K · Jan 29, 2025